Immunospecific Reduction of Antioligonucleotide Antibody-Forming Cells with a Tetrakis-oligonucleotide Conjugate (LJP 394), a Therapeutic Candidate for the Treatment of Lupus Nephritis
- 1 June 1995
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 38 (12) , 2138-2144
- https://doi.org/10.1021/jm00012a013
Abstract
Note: In lieu of an abstract, this is the article's first page.Keywords
This publication has 0 references indexed in Scilit: